FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer
Clinical trial NCT01896869 · COMPLETED
Trial details
- NCT number
- NCT01896869
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2019-05-03
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.